NCT02601898

Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment

Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Azienda USL Ferrara · Other Government
• Sex: Female
• Age: 24 Years – 37 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.

Conditions

• Subchorionic Hematoma in the First Trimester Pregnancy
• Miscarriage

Interventions

Type	Name	Description
DEVICE	Lipoic acid	Vaginal capsules (medical device) containing 10 mg of lipoic acid (1 per day)
DRUG	Progesterone	Vaginal capsules (drug) containing 200 mg of progesterone (2 per day)

Timeline

• Start date: 2015-01-01
• Primary completion: 2015-11-01
• First posted: 2015-11-11
• Last updated: 2016-01-08

Locations

1 site across 1 country: Italy